23 Mar 2017 | 9:00 AM
 

Divi`s Laboratories Ltd. Share Price Live (BSE)
0

BSE Code: 532488 | NSE Symbol: DIVISLAB
626.80
-7.55
(-1.19 %)
22 Mar 2017 | 03:58 PM
Change company
  • Open (Rs)
    630.00
  • Prev. close (Rs.)
    634.35
  • High (Rs.)
    639.50
  • Low (Rs.)
    611.60
  • 52W H (Rs.)
    1,380.00
  • 52W L (Rs.)
    611.60
  • Volume (Rs.)
    1215960
  • MCap (Rs in Cr.)
    16,639.60
627.4
-9.45
(-1.48 %)
  • Open (Rs)
    618.70
  • High (Rs)
    641.00
  • Low (Rs)
    612.00
  • Prev. close(Rs)
    636.85
  • Contracts Tra.
    1,29,62,400
  • Turnover (Cr.)
    813
  • Open Interest
    82,38,000
  • Open Int. chg
    6,67,200.00
1D| 1W| 1M | 3M | 6M | 1YR | MAX

Financials

EPS
64.15
Operating Margin (%)
37.40
Gross Profit Margin (%)
33.04
Net Profit Margin (%)
27.33
Total Debt/Equity
0.01
Dividend payout Ratio (Net Profit)
37.52
Earning Retention Ratio
62.48

News

22 Mar 2017 - 11:51:00-Shares of Divi's Laboratories continued losing streak of the second day and tanked over 3 per ce...
21 Mar 2017 - 12:07:00-Drug firm Divi's Laboratories Ltd on Tuesday said the US health regulator has issued an import a...
21 Mar 2017 - 11:50:00-Shares of Divi's Laboratories plunged nearly 20 per cent on the Bombay Stock Exchange after the ...
08 Dec 2016 - 10:51:00-Shares of Divi's Laboratories plunged over 6 per cent on the Bombay Stock Exchange after the com...

Announcements

22-Mar-2017
Divi`s Lab - Updates
21-Mar-2017
Divi`s Lab - Updates
04-Feb-2017
Divi`s Lab - Announces Q3 results (Standalone) Limited Review Report (Standalone) & Results Press Release for the Quarter en
23-Jan-2017
Divi`s Lab - Q3 results on Feb 04 2017
16-Jan-2017
Divi`s Lab - Shareholding for the Period Ended December 31 2016

Religare Research

22 Mar 2017 | 12:00 PM
Agri Fundamental and Technical report
22 Mar 2017 | 09:53 AM
The Indian rupee rose for a second day against the dollar, a sixth day of gain in seven sessions, as...
22 Mar 2017 | 09:34 AM
• Gold glittered as dollar tumbled • Oil fell as market discounted OPEC output cut extension talk • ...
22 Mar 2017 | 07:00 AM
We reiterate our bullish view on markets and suggest continuing with buy on dips approach. Nifty has...

Fund Interest

Schemes Shares Held Mkt. Value Latest Nav % Nav
24,33,441 575.29 76.70 -0.98
24,33,441 575.29 28.28 -0.98
24,33,441 575.29 76.70 -0.98
24,33,441 575.29 20.41 -0.98
24,33,441 575.29 79.20 -0.98

Shareholding Pattern

       
Promotors52.06%
Mutual Funds/UTI14.29%
FI/Banks0.29%
Insurance0.29%
FII19.81%
Government0.00%
Others6.56%

Peer Group

Company Intraday Graph
 Sanofi India Ltd.
4,631.00(1.25)
3325
 GlaxoSmithKline Pharmaceuticals Ltd.
2,755.60(0.11)
3317
 Dr. Reddy`s Laboratories Ltd.
2,626.60(0.14)
3294
 Alkem Laboratories Ltd.
2,161.00(1.56)
17141

Exchange Information

NSE Index
Sensex
CNX 100
BSENAT
CNX 200
BSE200
CNX Bank
BSE500
CNX500
BSE Midcap
CNX Midcap
BSE Smallcap
Note: The scrip is a constituent of those NSE and BSE indices that have against them.

Company Indices

 1M (%)3M (%)6M (%)
Divi``s Laboratories Ltd.-124.40-481.80-701.85
NIFTY(S&P CNX)103.551,051.35163.00
BSE SENSEX302.973,188.08394.55
BSE 500165.521,584.13396.20

Corporate Details

Key Personal
Kiran S Divi
President & Director
Madhusudana Rao Divi
Director - Projects
Murali K Divi
Chairman & Managing Director
Key Address
Registered Office
1-72/23(P)/DIVIS/303 Divi Towers Cyber Hills Gachibowli,Hyderabad,Telangana

Tel:040-23786300, Fax:040-23786460

mail@divislaboratories.com
http://www.divislaboratories.com
Registrar Office
In House

Make smart investment decisions with Star Ratings, a stock selection tool, based upon fundamental, technical and analyst recommendations. Star Ratings provides stock trading tips for Divi`s Laboratories Ltd. that will help you decide whether to buy, sell or hold Divi`s Laboratories Ltd. It also provides you with switch proposals on alternative stocks, i.e., which stocks to buy against Divi`s Laboratories Ltd.